Market Overview:
The global nucleic acid extraction equipment market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for nucleic acid extraction equipment in hospital and laboratory applications. Additionally, the growing demand for high throughput nucleic acid extraction equipment is also contributing to the growth of this market. North America dominates the global nucleic acid extraction equipment market, followed by Europe and Asia Pacific.
Product Definition:
Nucleic acid extraction equipment is used to extract nucleic acids from biological samples. The importance of nucleic acid extraction equipment is that it allows scientists to study the genetic material in a sample.
Low Throughput:
Low Throughput is a term used for the situation where there are less than 20 samples/hour in nucleic acid extraction equipment.
The key drivers of this market include increasing demand for automation in laboratories and rising number of research studies. In addition, continuous technological advancements such as the development of single-use systems and microarrays are also expected to fuel market growth over the forecast period.
Med Throughput:
Med Throughput is the maximum number of samples that can be processed in a unit of time. It depends on the capacity and configuration of the equipment, as well as, collection parameters. The extraction process is performed multiple times with different input materials to produce an average value for each run which is then used for calculating med throughput.
The nucleic acid extraction market has been witnessing significant growth over recent years owing to rising demand in various applications such as genetic testing.
Application Insights:
The other application segment includes food and beverages, biotechnology, diagnostics and therapeutics. The use of nucleic acid extraction equipment for the aforementioned applications is relatively less compared to that of a hospital or laboratory. However, with the increasing demand for personalized medicine through genetic analysis techniques such as DNA sequencing and methylation studies, there has been an increased focus on clinical research activities in recent times. This is anticipated to drive product demand over the forecast period.
In terms of revenue, the hospital segment dominated the global market in 2017 owing to an increase in number of cancer cases across various parts of globe coupled with rising awareness about early diagnosis procedures among consumers at large levels worldwide including emerging economies such as India China etc., which has positively influenced product sales over past few years globally speaking.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of major players, increased government funding for genomic studies, and high adoption of automation in clinical laboratories. Moreover, increasing prevalence of cancer is expected to drive regional growth over the forecast period. For instance, according to Cancer Statistics Canada’s annual publication released in 2018, an estimated 459 new cases were diagnosed in Manitoba and 738 new cases were diagnosed in Saskatchewan as per the Canadian Cancer Society's website: www.cancersocietycanada.ca/en/.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to rising healthcare expenditure by governments and private agencies coupled with growing awareness among people about early diagnosis leading towards higher treatment rates resulting into improved patient survival rates which would ultimately drive demand for nucleic acid extraction equipment over next eight years from 2018 till 2030 time frame ( Exhibit 1 ).
Growth Factors:
- Increasing demand for nucleic acid extraction from various sample types for downstream applications such as sequencing, genotyping, and gene expression analysis.
- Growing popularity of Next-Generation Sequencing (NGS) technology that requires high quality nucleic acids for sequencing library preparation.
- Proliferation of personalized medicine and companion diagnostics that require accurate detection of genetic variants in patient samples.
- Rising incidence of cancer and other diseases that necessitates diagnosis through analysis of DNA or RNA fragments isolated from clinical specimens.
Scope Of The Report
Report Attributes
Report Details
Report Title
Nucleic Acid Extraction Equipment Market Research Report
By Type
Low Throughput, Med Throughput, High Throughput
By Application
Hospital, Laboratory, Other
By Companies
Roche Life Science, Thermo Fisher Scientific, Qiagen, PerkinElmer, LGC, Promega, Kurabo Biomedical, Bruker (Hain), Analytik Jena, Bioneer, AutoGen, Biosan, ELITech, Genolution, GeneReach
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
219
Number of Tables & Figures
154
Customization Available
Yes, the report can be customized as per your need.
Global Nucleic Acid Extraction Equipment Market Report Segments:
The global Nucleic Acid Extraction Equipment market is segmented on the basis of:
Types
Low Throughput, Med Throughput, High Throughput
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Laboratory, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche Life Science
- Thermo Fisher Scientific
- Qiagen
- PerkinElmer
- LGC
- Promega
- Kurabo Biomedical
- Bruker (Hain)
- Analytik Jena
- Bioneer
- AutoGen
- Biosan
- ELITech
- Genolution
- GeneReach
Highlights of The Nucleic Acid Extraction Equipment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Low Throughput
- Med Throughput
- High Throughput
- By Application:
- Hospital
- Laboratory
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nucleic Acid Extraction Equipment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Nucleic acid extraction equipment is a laboratory tool used to isolate and purify nucleic acids from biological samples.
Some of the major players in the nucleic acid extraction equipment market are Roche Life Science, Thermo Fisher Scientific, Qiagen, PerkinElmer, LGC, Promega, Kurabo Biomedical, Bruker (Hain), Analytik Jena, Bioneer, AutoGen, Biosan, ELITech, Genolution, GeneReach.
The nucleic acid extraction equipment market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Nucleic Acid Extraction Equipment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Nucleic Acid Extraction Equipment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Nucleic Acid Extraction Equipment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Nucleic Acid Extraction Equipment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Nucleic Acid Extraction Equipment Market Size & Forecast, 2020-2028
4.5.1 Nucleic Acid Extraction Equipment Market Size and Y-o-Y Growth
4.5.2 Nucleic Acid Extraction Equipment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Low Throughput
5.2.2 Med Throughput
5.2.3 High Throughput
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Laboratory
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Nucleic Acid Extraction Equipment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Nucleic Acid Extraction Equipment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Low Throughput
9.6.2 Med Throughput
9.6.3 High Throughput
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Laboratory
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Low Throughput
10.6.2 Med Throughput
10.6.3 High Throughput
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Laboratory
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Low Throughput
11.6.2 Med Throughput
11.6.3 High Throughput
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Laboratory
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Low Throughput
12.6.2 Med Throughput
12.6.3 High Throughput
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Laboratory
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Low Throughput
13.6.2 Med Throughput
13.6.3 High Throughput
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Laboratory
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Nucleic Acid Extraction Equipment Market: Competitive Dashboard
14.2 Global Nucleic Acid Extraction Equipment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche Life Science
14.3.2 Thermo Fisher Scientific
14.3.3 Qiagen
14.3.4 PerkinElmer
14.3.5 LGC
14.3.6 Promega
14.3.7 Kurabo Biomedical
14.3.8 Bruker (Hain)
14.3.9 Analytik Jena
14.3.10 Bioneer
14.3.11 AutoGen
14.3.12 Biosan
14.3.13 ELITech
14.3.14 Genolution
14.3.15 GeneReach
